Avalyn Pharma Stock Surges 44% After Upsized $300M IPO on May 01, 2026 Avalyn AVLN IPO Pharma Pulmonary Fibrosis Stock Surge +
Compass Pathways Stock Soars on Second Phase 3 Success for Psilocybin Depression Treatment on February 17, 2026 COMP360 Compass Pathways Phase 3 trial Psilocybin Stock Surge submission treatment-resistant depression United States Food and Drug Administration +
Abivax Stock Surges on Reports of $17.5 Billion Eli Lilly Takeover Interest on January 13, 2026 Abivax ABVX Eli Stock Surge Takeover Twice a day +
Abivax Stock Surges on Reports of $17.5 Billion Eli Lilly Takeover Interest on January 12, 2026 Abivax ABVX Eli Stock Surge Takeover Twice a day +
Abivax Stock Surges on Reports of $17.5 Billion Eli Lilly Takeover Interest on January 12, 2026 Abivax ABVX Eli Stock Surge Takeover Twice a day +
Cogent Biosciences Soars on Positive Phase 3 PEAK Results in Gastrointestinal Stromal Tumors (GIST) on November 11, 2025 bezuclastinib Clinical Trials Cogent Biosciences Frequency of Responses Gastrointestinal Stromal Tumors NDA Phase 3 Progression-Free Survival Standard (qualifier) Stock Surge submission sunitinib +
Alnylam Surpasses $50B Market Cap as Amvuttra Heart Disease Launch Impresses Wall Street on August 01, 2025 Alnylam Amvuttra ATTR-CM Caps earnings Heart Diseases Market revenue growth Stock Surge +
GSK, Spero Report Major Phase 3 Win for UTI Antibiotic; Spero's Stock Surges on May 28, 2025 Antibiotics Clinical Trials Complicated HBr PIVOT-PO trial SmithKline Beecham Spero Therapeutics Stock Surge submission United States Food and Drug Administration Urinary tract infection +